FDA warns Hospira over problems at N.C. plant

03/18/2013 | MassDevice.com (Boston)

Hospira has received an FDA warning citing 20 issues found at its facility in Rocky Mount, N.C., after a three-week inspection. The company, which develops infusion systems and injectable drugs, said it is cooperating with the FDA regarding the matter and will respond to the findings with a plan for remediation and modernization.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA
Program Manager II
Tufts Health Plan/Network Health
Medford, MA
Director, Medicare Advantage/Medicare Part D Focus
Avalere Health
Washington, DC
Chief, Product Review Branch
FDA/Center for Biologics Evaluation and Research
Silver Spring, MD
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ